{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T03:42:58Z","timestamp":1770522178191,"version":"3.49.0"},"reference-count":35,"publisher":"Informa UK Limited","issue":"17","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319\u00a0","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319\u00a0","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.2217\/fon-2022-1267","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T09:03:41Z","timestamp":1684832621000},"page":"1197-1208","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["The Importance of Developing Open Communication and a Professional, Long-Term Relationship Between Patients with Chronic Myeloid Leukemia and their Oncologist"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4317-7553","authenticated-orcid":false,"given":"Joan","family":"Clements","sequence":"first","affiliation":[{"name":"Patient author, CML Buster Foundation, Costa Mesa,CA92627,USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Fleischman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, University of California, Irvine,CA92697,USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Lerner","sequence":"additional","affiliation":[{"name":"Patient author, CML Buster Foundation, Costa Mesa,CA92627,USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ruiz","sequence":"additional","affiliation":[{"name":"Patient author, CML Buster Foundation, Costa Mesa,CA92627,USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30694"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0b013e3182086fe1"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/0141076818769477"},{"issue":"1","key":"e_1_3_4_6_1","first-page":"38","article-title":"Doctor-patient communication: a review","volume":"10","author":"Ha JF","year":"2010","unstructured":"Ha JF , LongneckerN. Doctor-patient communication: a review. Ochsner J10(1), 38\u201343 (2010).","journal-title":"Ochsner J"},{"issue":"2","key":"e_1_3_4_7_1","first-page":"131","article-title":"The influence of doctor-patient communication on health outcomes: a systematic review","volume":"63","author":"Riedl D","year":"2017","unstructured":"Riedl D , Sch\u00fc\u00dflerG. The influence of doctor-patient communication on health outcomes: a systematic review. Z Psychosom Med Psychother63(2), 131\u2013150 (2017).","journal-title":"Z Psychosom Med Psychother"},{"issue":"5","key":"e_1_3_4_8_1","article-title":"Impact of the doctor-patient relationship","volume":"17","author":"Chipidza FE","year":"2015","unstructured":"Chipidza FE , WallworkRS, SternTA. Impact of the doctor-patient relationship. Prim Care Companion CNS Disord17(5), (2015).","journal-title":"Prim Care Companion CNS Disord"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.7034"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2014.297"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2023-0402"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2023-0403"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2023-0404"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25792"},{"key":"e_1_3_4_15_1","unstructured":"The CML guide: information for patients and caregivers. https:\/\/www.lls.org\/booklet\/cml-guide-information-patients-and-caregivers (2022)."},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-501569"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000165"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.4663"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-018-0449-7"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26679"},{"key":"e_1_3_4_21_1","unstructured":"Cancer stat facts: leukemia - chronic myeloid leukemia (CML). https:\/\/seer.cancer.gov\/statfacts\/html\/cmyl.html (2022)."},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0776-2"},{"key":"e_1_3_4_23_1","unstructured":"Highlights of prescribing information: Gleevec (imatinib mesylate). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/021588s056s057lbl.pdf (2022)."},{"key":"e_1_3_4_24_1","unstructured":"Highlights of prescribing information: Sprycel (dasatinib). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/021986s021lbl.pdf (2022)."},{"key":"e_1_3_4_25_1","unstructured":"Highlights of prescribing information: Bosulif (bosutinib). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/203341lbl.pdf (2022)."},{"key":"e_1_3_4_26_1","unstructured":"Highlights of prescribing information: Tasigna (nilotinib). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/022068s031lbl.pdf (2022)."},{"key":"e_1_3_4_27_1","unstructured":"Highlights of prescribing information: Iclusig (ponatinib). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/203469s033lbl.pdf (2022)."},{"key":"e_1_3_4_28_1","unstructured":"Highlights of prescribing information: Scemblix (asciminib). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/215358s000Orig1lbl.pdf (2022)."},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2019-0555"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2372-z"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.5581\/1516-8484.20140014"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23180"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31050"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2012.04.002"},{"issue":"1","key":"e_1_3_4_35_1","first-page":"29","article-title":"Patient-centered communication: basic skills","volume":"95","author":"Hashim MJ","year":"2017","unstructured":"Hashim MJ . Patient-centered communication: basic skills. Am. Fam. Physician95(1), 29\u201334 (2017).","journal-title":"Am. Fam. Physician"},{"key":"e_1_3_4_36_1","unstructured":"Treatment-free remission for chronic myeloid leukemia patients. https:\/\/www.lls.org\/sites\/default\/files\/National\/USA\/Pdf\/Publications\/FS34_Treatment_Free_Remission2018.pdf (2022)."},{"key":"e_1_3_4_37_1","unstructured":"Do I tell anyone I have cancer? https:\/\/www.lls.org\/managing-your-cancer\/do-i-tell-anyone-i-have-cancer (2023)."}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2022-1267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:44:31Z","timestamp":1719125071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2022-1267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":35,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.2217\/fon-2022-1267"],"URL":"https:\/\/doi.org\/10.2217\/fon-2022-1267","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-12-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}